Elias Zerhouni - Danaher Independent Director
| DHER34 Stock | BRL 50.55 0.65 1.27% |
Director
Dr. Elias A. Zerhouni, M.D. is Independent Director of the Company. Dr. Zerhouni has served as President, Global Research Development, for Sanofi S.A., a global pharmaceutical company, since January 2011. From 2008 until 2011, he provided advisory and consulting services to various nonprofit and other organizations as Chairman and President of Zerhouni Holdings. From 2002 to 2008, Dr. Zerhouni served as director of the National Institutes of Health, and from 1996 to 2002, he served as Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences, Vice Dean for Research and Executive Vice Dean of the Johns Hopkins School of Medicine. Dr. Zerhouni, a physician, scientist and worldrenowned leader in radiology research, is widely viewed as one of the leading authorities in the United States on emerging trends and issues in medicine and medical care. These insights, as well as his deep, technical knowledge of the research and clinical applications of medical technologies, are of considerable importance given Danahers strategic focus in the medical technologies markets since 2009.
| Age | 67 |
| Tenure | 15 years |
| Phone | 202 828 0850 |
| Web | https://www.danaher.com |
Elias Zerhouni Latest Insider Activity
Tracking and analyzing the buying and selling activities of Elias Zerhouni against Danaher stock is an integral part of due diligence when investing in Danaher. Elias Zerhouni insider activity provides valuable insight into whether Danaher is net buyers or sellers over its current business cycle. Note, Danaher insiders must abide by specific rules, including filing SEC forms every time they buy or sell Danaher'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Elias Zerhouni over a year ago Acquisition by Elias Zerhouni of 216 shares of Danaher subject to Rule 16b-3 |
Danaher Management Efficiency
The company has return on total asset (ROA) of 0.0648 % which means that it generated a profit of $0.0648 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1513 %, meaning that it generated $0.1513 on every $100 dollars invested by stockholders. Danaher's management efficiency ratios could be used to measure how well Danaher manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 6 records | DIRECTOR Age | ||
| Richard Johannpeter | Metalurgica Gerdau SA | 44 | |
| Parker Harris | salesforce inc | 56 | |
| Affonso Pastore | Metalurgica Gerdau SA | 79 | |
| Edward Egl | Waste Management | N/A | |
| Aod Moraes | Metalurgica Gerdau SA | N/A | |
| Fernando Iunes | Metalurgica Gerdau SA | 56 | |
Management Performance
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0648 |
Danaher Leadership Team
Elected by the shareholders, the Danaher's board of directors comprises two types of representatives: Danaher inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Danaher. The board's role is to monitor Danaher's management team and ensure that shareholders' interests are well served. Danaher's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Danaher's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rainer Blair, President, Chief Executive Officer, Director | ||
| Angela Lalor, Senior Vice President - Human Resources | ||
| Pardis Sabeti, Independent Director | ||
| William King, Senior Vice President - Strategic Development | ||
| Matthew McGrew, Chief Financial Officer, Executive Vice President | ||
| Thomas Joyce, President, Chief Executive Officer, Director | ||
| Mitchell Rales, CoFounder Director | ||
| JoseCarlos GutierrezRamos, Senior Vice President Chief Scientific Officer | ||
| John Schwieters, Independent Director | ||
| Linda Filler, Lead Independent Director | ||
| Teri ListStoll, Independent Director | ||
| Daniel Raskas, Senior Vice President - Corporate Development | ||
| Daniel Comas, CFO, Executive Vice President | ||
| Elias Zerhouni, Independent Director | ||
| Brian Ellis, Senior Vice President, Chief Compliance Officer, General Counsel | ||
| Raymond Stevens, Independent Director | ||
| Jessica Mega, Independent Director | ||
| Steven Rales, Chairman of the Board | ||
| John Bedford, VP Relations | ||
| Alan Spoon, Independent Director | ||
| Robert Lutz, Senior Vice President Chief Accounting Officer | ||
| Walter Lohr, Independent Director | ||
| Christopher Bouda, Chief Officer | ||
| Joakim Weidemanis, Executive Vice President | ||
| Jennifer Honeycutt, Executive Vice President |
Danaher Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Danaher a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0648 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 1.11 T | |||
| Shares Outstanding | 20.39 B | |||
| Price To Earning | 13.01 X | |||
| Price To Book | 4.36 X | |||
| Price To Sales | 33.27 X | |||
| Revenue | 31.47 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Danaher Stock
When determining whether Danaher is a strong investment it is important to analyze Danaher's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Danaher's future performance. For an informed investment choice regarding Danaher Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Danaher. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Danaher Stock refer to our How to Trade Danaher Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.